PRESS RELEASE published on 09/25/2023 at 06:55, 1 year 1 month ago Polymetal: Half-year report for the six month ended 30 June 2023
PRESS RELEASE published on 08/10/2023 at 08:00, 1 year 3 months ago Polymetal: Resumption of trading on AIX
PRESS RELEASE published on 08/09/2023 at 08:00, 1 year 3 months ago Polymetal: Q2 2023 production results
PRESS RELEASE published on 08/08/2023 at 06:00, 1 year 3 months ago Polymetal: Re-Domiciliation to AIFC Completed
PRESS RELEASE published on 08/01/2023 at 19:00, 1 year 3 months ago Polymetal: Suspension of Trading on the London Stock Exchange
PRESS RELEASE published on 07/24/2023 at 16:00, 1 year 3 months ago Polymetal: Q2 2023 production results webcast
Published on 11/21/2024 at 14:15, 9 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 24 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 24 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 24 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 8 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 9 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 49 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 26 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 4 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 39 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 39 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo